Skip to main content
Figure 9 | Respiratory Research

Figure 9

From: Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma

Figure 9

Beneficial bacteria and budesonide suppress airway remodelling features in chronic asthmatic mice. Representative photomicrographs for 5 mice/group of hitstological and immunohistochemical staining for inflammation (hematoxylin-eosin, HE); goblet cells (periodic acid Schiff, PAS); connective tissue (Masson trichrome, Masson); Anti-α-smooth muscle actin (α-smooth muscle) and proliferating cells (Anti-Ki67) in lung tissue of sensitised only (OVA/Sal) and sensitised and challenged (OVA/OVA) mice treated with PBS, B. breve, L. rhamnosus or budesonide (BUD). Original magnification, 40X, except for anti-Ki67 100X.

Back to article page